Exposure‐response Relationships for the Efficacy and Safety of Filgotinib and Its Metabolite GS‐829845 in Subjects with Rheumatoid Arthritis Based on Phase 2 and Phase 3 Studies
British Journal of Clinical Pharmacology（2022）
关键词
drug safety,PK-PD,randomized controlled trial,rheumatoid arthritis,therapeutics,Specialties,filgotinib,JAK inhibitors,exposure-response
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要